EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia Lymphoma
Condition(s):Leukemia-Lymphoma, Adult T-CellLast Updated:March 28, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Leukemia-Lymphoma, Adult T-CellLast Updated:March 28, 2017Completed
Condition(s):Adult T-cell Leukemia-Lymphoma; Peripheral T-cell LymphomaLast Updated:November 8, 2019Completed
Condition(s):Adult T-cell Leukemia; LymphomaLast Updated:September 22, 2016Completed
Condition(s):Constitutional Tall StatureLast Updated:April 6, 2016Unknown status
Condition(s):Adult T-cell Leukemia-LymphomaLast Updated:March 30, 2017Completed
Condition(s):Acute Adult T-Cell Leukemia/Lymphoma; Adult T-Cell Leukemia/Lymphoma; Chronic Adult T-Cell Leukemia/Lymphoma; HTLV-1 InfectionLast Updated:March 6, 2024Recruiting
Condition(s):T-ALL, T-NHL (Lymphoblastic)Last Updated:August 18, 2022Completed
Condition(s):Lymphoma; Adult T-Cell Leukemia/Lymphoma; Lymphatic DiseasesLast Updated:December 19, 2023Active, not recruiting
Condition(s):HTLV-I Associated Adult T-cell Leukaemia/Lymphoma (ATLL)Last Updated:August 22, 2011Completed
Condition(s):Adult T-Cell Lymphoma/Leukemia; Sezary Syndrome; Mycosis FungoidesLast Updated:January 4, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.